about
ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signalingOvarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinomaProtein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitorsReinterpretation of evidence advanced for neo-oogenesis in mammals, in terms of a finite oocyte reserveEvaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monoculturesDeveloping ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention.Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population.Extracellular molecules involved in cancer cell invasionEnhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsulesExpression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer PatientsMolecular staging of gynecological cancer: What is the future?Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells.Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguityCD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer.Development of enantioselective synthetic routes to (-)-kinamycin F and (-)-lomaiviticin aglycon.STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.Human ovarian cancer stroma contains luteinized theca cells harboring tumor suppressor gene GT198 mutationsImpact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted celReproductive tract function and dysfunction in women.Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.Cancer stem cells, microRNAs, and therapeutic strategies including natural products.Drug treatment of cancer cell lines: a way to select for cancer stem cells?Lung cancer stem cells and implications for future therapeutics.Cancer stem cell detection and isolation.Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.VSV based virotherapy in ovarian cancer: the past, the present and …future?Cancer stem cells as functional biomarkers.Adipocyte microenvironment promotes Bclxl expression and confers chemoresistance in ovarian cancer cells.Characterization of cancer stem cells from different grades of human colorectal cancer.Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance.
P2860
Q21131951-1393B7CF-D983-4CF6-A6D3-D87700C60D59Q26826899-BE37B5E7-A787-4C57-94AF-AF56DB7D8E05Q26998068-1171C604-93A9-4885-B42A-FA46216158C3Q34383397-BDD59CD1-6BE4-4EDA-8432-C1F7A255D201Q34483738-52F52578-0C83-4848-95C5-A7404A7812F9Q34510690-F4D8886D-921B-4B2B-9852-2791843F3187Q34569444-BC748788-B2C4-42C9-9361-76FD0634AE28Q34968735-49FDEA88-9CE0-4CF6-A49A-064DC9A3150FQ35200985-EB541117-0433-4ED3-BCCB-9851603F98AAQ35237503-164731A9-7F45-4F69-AC7E-8F500811B4F4Q35514837-AC8E1E94-D4C8-458A-A739-E0AE70D994DEQ35745018-5FAE4124-8E6F-43DC-A008-CAB82BE74FA3Q35844366-B4A3E32D-E54E-48C0-BA1C-58968BF5A98AQ35940829-C77DE361-4FD7-410C-B73D-A0DD3B8FF7EDQ36012912-B9398F57-BFA3-4493-801A-DB377A7E2BFAQ36014411-65CC7A21-4546-4E4A-A885-CF2B0EE6CA26Q36406924-1A066237-49A4-4CE1-BFFC-08FD341D3038Q36421339-D99A5D46-0B98-4DB4-AAC8-B496BA8B2008Q36761363-E7721A17-BCB6-428B-9570-B487D65EBAD8Q37196532-053E6B95-967B-4AB2-8E15-A345A20FCD8AQ37311456-1D65640C-7C5A-4F77-9F35-D67A0A91BE69Q37337898-4715D9A0-81A9-4A72-BCBE-F668D4EFCFE2Q37694661-8F7968E2-4DF3-4D70-93BF-0140BAB83BC5Q37716584-50887716-62C1-4F46-83DB-EEA46D138388Q37879446-397637C1-58C6-496B-906A-C21E393FECD7Q37978771-B366CE0E-2CD5-495E-85C1-22B0594C8C6FQ38023238-2BDBB273-4D9A-4DC4-8A5E-AEB86C165C62Q38161343-691A557A-9D09-41D9-B495-945EEAD61867Q38189297-886939FE-10DE-4EC3-9609-4DF214989DAEQ38234251-A1ED4297-50E2-4228-82D8-E17A51FC984AQ38800430-45C06668-008E-4DFA-818C-7FE3A713057CQ41441101-F51ED368-8393-450E-942C-40FC9FFB5CC6Q50505302-3A2C0380-9E8F-4CE0-B725-3AD0B7488F3AQ51238643-423D77B7-B92A-4481-9484-9CC17D58A684Q51581224-323F7669-6C52-44F6-8650-E5C4632E9EB1Q53697399-3FFD9446-2E5E-414E-B985-B727E11DCE64
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human ovarian cancer stem cells.
@en
Human ovarian cancer stem cells.
@nl
type
label
Human ovarian cancer stem cells.
@en
Human ovarian cancer stem cells.
@nl
prefLabel
Human ovarian cancer stem cells.
@en
Human ovarian cancer stem cells.
@nl
P356
P1433
P1476
Human ovarian cancer stem cells.
@en
P2093
Sharmila A Bapat
P356
10.1530/REP-09-0389
P577
2010-03-16T00:00:00Z